WRF
DPLO

Waddell & Reed Financial’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Waddell & Reed Financial’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-1,491,940
Closed -$18.8M – 603
2016
Q4 		$18.8M Sell
1,491,940
-42,086
-3% -$784K 0.04% 344
2016
Q3 		$43M Buy
1,534,026
+70,000
+5% +$2.35M 0.09% 224
2016
Q2 		$51.2M Buy
1,464,026
+84,861
+6% +$2.67M 0.11% 199
2016
Q1 		$37.8M Buy
1,379,165
+87,709
+7% +$2.58M 0.07% 231
2015
Q4 		$44.2M Buy
1,291,456
+130,880
+11% +$4.08M 0.07% 221
2015
Q3 		$33.3M Buy
+1,160,576
New +$49.6M 0.05% 253

Other funds holding DPLO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
HIM
Hermes Investment Management London Uk, United Kingdom $7.52B AUM 20.67% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $23.3B AUM 26.95% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Waddell & Reed Financial's DPLO Position: Q1 2017 in Review

Waddell & Reed Financial sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2017, closing a stake of 1,491,940 shares — an estimated $18.8M sold.

Waddell & Reed Financial first reported a position in DPLO in Q3 2015 and held it in 6 quarters. The position peaked at $51.2M in Q2 2016. 155 funds tracked by Wall St. Rank hold DPLO as of Q1 2017.

  • Waddell & Reed Financial reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2017 after selling out during the quarter.
  • Waddell & Reed Financial sold 1,491,940 DIPLOMAT PHARMACY, INC. shares in Q1 2017, an estimated $18.8M.
  • Waddell & Reed Financial first reported a position in DIPLOMAT PHARMACY, INC. in Q3 2015 and held it in 6 quarters.
  • Waddell & Reed Financial's DIPLOMAT PHARMACY, INC. position peaked at $51.2M in Q2 2016.
  • 155 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2017.

Based on Waddell & Reed Financial's 13F filing for Q1 2017, filed 15 May 2017.